Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
300
NCT05433974
Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk
Phase: N/A
Role: Collaborator
Start: Oct 1, 2022
Completion: Jun 1, 2024
NCT06033183
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
Role: Lead Sponsor
Start: Dec 2, 2023
Completion: Oct 30, 2027